Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.verified

TERN

Price:

$6

Market Cap:

$388.06M

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase Ib clinical trial for the treatment of NASH. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase I clinical trial for the treatment of NASH; and TERN-601, a smal...[Read more]

Industry

Biotechnology

IPO Date

2021-02-05

Stock Exchange

NASDAQ

Ticker

TERN

The PE Ratio as of May 2024 (TTM) for Terns Pharmaceuticals, Inc. (TERN) is -4.76

According to Terns Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.76. This represents a change of -18.04% compared to the average of -5.81 of the last 4 quarters.

Terns Pharmaceuticals, Inc. (TERN) Historical PE Ratio (quarterly & annually)

How has TERN PE Ratio performed in the past?

The mean historical PE Ratio of Terns Pharmaceuticals, Inc. over the last ten years is -9.63. The current -4.76 PE Ratio has changed 4.85% with respect to the historical average. Over the past ten years (40 quarters), TERN's PE Ratio was at its highest in in the June 2022 quarter at -1.13. The PE Ratio was at its lowest in in the March 2020 quarter at -12.24.

Quarterly (TTM)
Annual

Average

-9.63

Median

-6.39

Minimum

-24.89

Maximum

-3.56

Terns Pharmaceuticals, Inc. (TERN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Terns Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 70.66%

Maximum Annual PE Ratio = -3.56

Minimum Annual Increase = -73.06%

Minimum Annual PE Ratio = -24.89

Quarterly (TTM)
Annual
YearPE RatioChange
2023-5.13-15.66%
2022-6.0870.66%
2021-3.56-68.72%
2020-11.3969.82%
2019-6.71-73.06%

Terns Pharmaceuticals, Inc. (TERN) Average PE Ratio

How has TERN PE Ratio performed in the past?

The current PE Ratio of Terns Pharmaceuticals, Inc. (TERN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-4.92

5-year avg

-6.57

10-year avg

-9.63

Terns Pharmaceuticals, Inc. (TERN) PE Ratio vs. Peers

How is TERN’s PE Ratio compared to its peers?

Terns Pharmaceuticals, Inc.’s PE Ratio is less than Amylyx Pharmaceuticals, Inc. (-1.65), less than Acumen Pharmaceuticals, Inc. (-3.64), less than Inozyme Pharma, Inc. (-3.66), less than X4 Pharmaceuticals, Inc. (-1.40), greater than Mereo BioPharma Group plc (-58.75), less than PDS Biotechnology Corporation (-2.44), less than HOOKIPA Pharma Inc. (-2.11), greater than Day One Biopharmaceuticals, Inc. (-5.71), less than Eledon Pharmaceuticals, Inc. (-2.12),

Build a custom stock screener for Terns Pharmaceuticals, Inc. (TERN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Terns Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Terns Pharmaceuticals, Inc. (TERN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Terns Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Terns Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Terns Pharmaceuticals, Inc. (TERN)?

What is the highest PE Ratio for Terns Pharmaceuticals, Inc. (TERN)?

What is the 3-year average PE Ratio for Terns Pharmaceuticals, Inc. (TERN)?

What is the 5-year average PE Ratio for Terns Pharmaceuticals, Inc. (TERN)?

How does the current PE Ratio for Terns Pharmaceuticals, Inc. (TERN) compare to its historical average?